Alnylam

Capella

Search
Welcome to Capella

Capella is the brightest star in the constellation Auriga. It is also a unified, focused vocal arrangement. For Alnylam, Capella is our online voice for communicating the scientific progress we are making as we translate the science of RNAi into human clinical experience and ultimately towards the development of innovative medicines for patients.

Send us your feedback
Subscribe
Tags
Leadership in RNAi, Regulus, Delivery, 5x15, TTR-Mediated Amyloidosis, Clinical Trials, RNAi Clinical Trials, Podcasts, Respiratory Syncytial Virus, Severe Hypercholesterolemia, Hemophilia, RNA-platform, conjugate, LNP, pre-clinical, Liver Cancers, RNAi Therapeutics, Huntington's Disease, ALN-TTRsc, hypercholesterolemia
Archives
Twitter

loading tweets...

More Tweets

Posts Tagged with: Huntington’s Disease

November 11, 2011

Continue reading…

June 15, 2011

In June 2011, our scientists presented an update on our Huntington’s disease program, ALN-HTT, at the 26^th Annual HDSA National Convention.

February 1, 2011

October 16, 2007

This part of our website contains archived information which should not be considered current and may no longer be accurate.